Treatment with LY2409021, a glucagon receptor antagonist, increases liver fat in patients with type 2 diabetes

Cristina B. Guzman, Xiaotian M. Zhang, Rong Liu, Arie Regev, Sudha Shankar, Parag Garhyan, Sreekumar G. Pillai, Christof Kazda, Naga Chalasani, Thomas A. Hardy

Research output: Contribution to journalArticle

43 Scopus citations

Fingerprint Dive into the research topics of 'Treatment with LY2409021, a glucagon receptor antagonist, increases liver fat in patients with type 2 diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences